Security key
79400X107
SALARIUS PHARMACEUTICALS INC - COM NEW (SLRX)
CUSIP: 79400X107
Q4 2019 13F Holders as of 31 Dec 2019
- Security type / class
- Equity / COM NEW
- Total 13F shares
- 222,447
- Total 13F value
- $839,000
- Share change
- -33,731
- SEC-reported price per share
- $3.75
- Number of holders
- 12
- Value change
- -$165,831
- Number of buys
- 3
- Number of sells
- 7
Report period
Q4 2019
Institutions
12
Top holders
10
SLRX full security history
Ownership snapshot
Full 13F holder table
Decoy Therapeutics Inc. SEC filings
Decoy Therapeutics Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of SLRX - SALARIUS PHARMACEUTICALS INC - COM NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Douglass Winthrop Advisor...
Disclosed value leader
Douglass Winthrop Advisor...
Comparable rows
0/12
Latest evidence
30 Sep 2019
13F
Highest disclosed value: $429,000
12 rows are not safely comparable across share classes.
Showing 1-6 of 12 holder rows.
Quick read
Douglass Winthrop Advisors, LLC has the largest disclosed position value at $429K.
0 of 12 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Douglass Winthrop Advisors, LLC's linked filing trail.
Disclosed position value
Top 5
Douglass Winthrop Advisors, LLC
$429K
RENAISSANCE TECHNOLOGIES LLC
$306K
Laird Norton Wetherby Wealth Mana...
$271K
TWO SIGMA SECURITIES, LLC
$119K
Financial Advocates Investment Ma...
$119K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 12 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Douglass Winthrop Advisors, LLC |
13F
Company
|
—
denominator unverified
|
$429,000
78,806 shares
|
— | 30 Sep 2019 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
—
denominator unverified
|
$306,000
56,219 shares
|
— | 30 Sep 2019 |
| Laird Norton Wetherby Wealth Management, LLC |
13F
Company
|
—
denominator unverified
|
$271,000
49,746 shares
|
— | 30 Sep 2019 |
| TWO SIGMA SECURITIES, LLC |
13F
Company
|
—
denominator unverified
|
$119,000
21,868 shares
|
— | 30 Sep 2019 |
| Financial Advocates Investment Management |
13F
Company
|
—
denominator unverified
|
$119,000
21,772 shares
|
— | 30 Sep 2019 |
| ACADIAN ASSET MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$97,000
17,933 shares
|
— | 30 Sep 2019 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2019
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
12
Shares
222,447
Rows available
12
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2019 vs Q3 2019 Across Filers
Q3 2019 holders
12
Q4 2019 holders
12
Holder diff
0
| Investor | Q3 2019 Shares | Q4 2019 Shares | Share Diff | Share Chg % | Q3 2019 value | Q4 2019 value | Value change | Value Chg % |
|---|